The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
We support our operations at KFF from our endowment and from external funds, which mostly come from foundations and a small number of individual donors. We use external funds chiefly for the incremental costs of projects we could not otherwise undertake. Today, external funding represents about 30% of our overall operating budget.
Charles N. Kahn III is a senior visiting fellow at KFF, where he hosts the podcast KFF's Business of Health with Chip Kahn. He is also a visiting senior fellow at the American Enterprise Institute (AEI) and a nonresident senior scholar at the University of Southern California's Schaeffer Center for Health Policy & Economics.
Virtually all (98.9%) of the 2.6 million Medicare beneficiaries enrolled in a Medicare Advantage plan that terminated coverage at the end of 2025 have at least one MA-PD available in 2026, including more than two-thirds (68.7%) who have the option of enrolling in a plan sponsored by the same insurer.
To provide context for emerging debates about federal actions to address prescription drug costs, this issue brief highlights five key facts about Medicaid prescription drug coverage, payment, and administration.
As the Trump administration promotes its new TrumpRx website and other efforts to lower prescription drug prices, a growing majority of the public worries about being able to afford prescription drugs, and large majorities across parties want the government to do more to regulate prices, a new KFF Health Tracking Poll finds.
Amid the Trump administration's focus on lowering prescription drug costs, including its new TrumpRx website, KFF's Health Tracking Poll finds that most Americans (59%) are worried about affording prescription drugs and support more regulation of prescription drug pricing (72%). Looking ahead to the 2026 midterm elections, the Democratic party currently holds the advantage when it comes to who voters trust to address the cost of health care, including prescription drugs.
This issue brief describes recent trends in the number of Medicaid outpatient prescriptions and the spending on those drugs and examines the implications of recent federal actions on future trends.
This tracker provides up-to-date information on countries with signed bilateral MOU global health agreements with the U.S.
Exposure to gun violence can have severe adverse effects on the mental health and well-being of children and adolescents, including increased likelihood of depression, PTSD, anxiety, and poor academic performance. This brief explores these impacts in addition to the various ways in which youth are exposed to gun violence, both directly and indirectly.
This brief analyzes the latest youth mortality data from the CDC, finding that nearly 22,000 children and adolescents died by firearm in the past decade. More information on trends over time, type of firearm deaths, and how these deaths vary by demographic and state are available in this brief.
© 2026 KFF